Last reviewed · How we verify
Placebo for SCH 697243
Placebos do not have an active pharmacological mechanism; they are used as controls in clinical trials.
At a glance
| Generic name | Placebo for SCH 697243 |
|---|---|
| Sponsor | ALK-Abelló A/S |
| Modality | Biologic |
| Phase | Phase 3 |
Mechanism of action
Placebos are designed to appear identical to the active drug being tested but contain no active ingredients. They help researchers determine the true effect of the active drug by comparing outcomes against a baseline where only psychological factors may influence the result.
Approved indications
Common side effects
Key clinical trials
- A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067) (PHASE3)
- Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED) (PHASE3)
- Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo for SCH 697243 CI brief — competitive landscape report
- Placebo for SCH 697243 updates RSS · CI watch RSS
- ALK-Abelló A/S portfolio CI